Evidence suggests a potential causal link for psoriasis and cardiovascular disease (CVD).
Health care costs for systemic treatment patterns and associated anxiety and depression in patients with psoriasis who began conventional systemic treatment are assessed.
Asian patients with psoriasis receive significantly less face-to-face time with a dermatologist than patients of other races and ethnicities.
The approval was based on data from the two phase 3 trials that included patients aged 12 years and older with mild to severe plaque psoriasis.
Researchers report the results of 2 patients with erythrodermic psoriasis–unresponsive to classic therapies–treated with golimumab.
Improvements in health-related quality of life measures in patients with psoriasis treated with brodalumab are assessed.
A novel study identifies significant clinical determinants affecting therapeutic choices in the treatment of long-term plaque psoriasis.
Various ultraviolet therapies for psoriasis treatment are compared for efficacy and safety.
An artificial intelligence (AI) system could aid clinicians in assessing psoriasis severity.
The prevalence of metabolic syndrome in patients with psoriasis is assessed.